Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Introduction to Innate and Adaptive Immunity

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Same author

H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell line.

Immunogenetics·2011

Same author

T-cell death and cancer immune tolerance.

Cell death and differentiation·2007

Same author

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.

The Journal of experimental medicine·2001

Same author

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

Cancer research·2001

Same author

Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicity.

Protein expression and purification·2001

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Innate and adaptive immunity in lung cancer.

L A Vella¹, O J Finn

¹Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15261, USA.

Novartis Foundation Symposium

|February 7, 2007

Summary

The innate immune system detects pathogens and cancer, signaling adaptive immunity. Tumor antigens like MUC1 and cyclin B1 are key targets, but chronic immune activation can lead to immunosuppression in cancer patients.

Area of Science:

Immunology
Oncology
Cancer Research

Background:

The immune system, comprising innate and adaptive branches, protects against pathogens and cancer.
Antigen-presenting cells bridge innate and adaptive immunity, orchestrating pathogen elimination and memory response.
Tumor antigens are crucial for cancer immunity, alerting the immune system to malignant cells.

Purpose of the Study:

To explore the roles of MUC1 and cyclin B1 as lung tumor-specific antigens.
To elucidate their interactions with innate and adaptive immunity.
To discuss cancer-induced immunosuppression resulting from chronic immune activation.

Main Methods:

Review of existing literature on MUC1, cyclin B1, and immune responses in lung cancer.
Analysis of molecular interactions between tumor antigens and immune cells.

More Related Videos

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

Related Experiment Videos

Last Updated: Jul 17, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

Discussion of the impact of chronic innate immune activation on adaptive immunity.

Main Results:

MUC1 and cyclin B1 are identified as key players in lung tumor-specific immunity.
These antigens engage both innate and adaptive immune pathways.
Chronic innate immune activation in cancer patients leads to adaptive immune suppression.

Conclusions:

MUC1 and cyclin B1 are critical targets for anti-cancer immunity.
Understanding their immune interactions is vital for developing effective cancer therapies.
Addressing immunosuppression is essential for successful cancer treatment.